Harrow, Inc. (HROW)
39.80
-1.15
(-2.81%)
USD |
NASDAQ |
Aug 24, 16:00
39.78
-0.02
(-0.05%)
After-Hours: 20:00
Harrow Enterprise Value : 1.708B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.708B |
| August 21, 2026 | 1.751B |
| August 20, 2026 | 1.793B |
| August 19, 2026 | 1.777B |
| August 18, 2026 | 1.698B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.717B |
| August 13, 2026 | 1.674B |
| August 12, 2026 | 1.692B |
| August 11, 2026 | 1.694B |
| August 10, 2026 | 1.742B |
| August 07, 2026 | 1.732B |
| August 06, 2026 | 1.713B |
| August 05, 2026 | 1.694B |
| August 04, 2026 | 1.709B |
| August 03, 2026 | 1.682B |
| July 31, 2026 | 1.670B |
| July 30, 2026 | 1.676B |
| July 29, 2026 | 1.666B |
| July 28, 2026 | 1.690B |
| July 27, 2026 | 1.621B |
| July 24, 2026 | 1.658B |
| July 23, 2026 | 1.786B |
| July 22, 2026 | 1.822B |
| July 21, 2026 | 1.855B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.883B |
| July 17, 2026 | 1.965B |
| July 16, 2026 | 1.899B |
| July 15, 2026 | 1.826B |
| July 14, 2026 | 1.767B |
| July 13, 2026 | 1.784B |
| July 10, 2026 | 1.809B |
| July 09, 2026 | 1.826B |
| July 08, 2026 | 1.906B |
| July 07, 2026 | 1.946B |
| July 06, 2026 | 1.901B |
| July 02, 2026 | 1.819B |
| July 01, 2026 | 1.828B |
| June 30, 2026 | 1.808B |
| June 29, 2026 | 1.739B |
| June 26, 2026 | 1.774B |
| June 25, 2026 | 1.752B |
| June 24, 2026 | 1.796B |
| June 23, 2026 | 1.800B |
| June 22, 2026 | 1.786B |
| June 18, 2026 | 1.803B |
| June 17, 2026 | 1.769B |
| June 16, 2026 | 1.637B |
| June 15, 2026 | 1.657B |
| June 12, 2026 | 1.608B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viatris, Inc. | 31.32B |
| Zevra Therapeutics, Inc. | 471.26M |
| Indivior Pharmaceuticals, Inc. | 4.556B |
| Liquidia Corp. | 6.160B |
| 60 Degrees Pharmaceuticals, Inc. | 11.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.27M |
| Revenue (Quarterly) | 70.66M |
| Total Expenses (Quarterly) | 87.93M |
| EPS Diluted (Quarterly) | -0.4624 |
| Gross Profit Margin (Quarterly) | 71.27% |
| Profit Margin (Quarterly) | -24.44% |
| Earnings Yield | -2.51% |
| Operating Earnings Yield | 0.38% |
| Normalized Earnings Yield | -1.762 |